Amgen Inc. (AMGN) Financials Nov 20, 2014, 5:58 p.
Post# of 250602
Posted On: 11/20/2014 7:44:28 PM
Amgen Inc. (AMGN) Financials Nov 20, 2014, 5:58 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Amgen Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 14.65B 15.01B 15.69B 17.19B 18.67B
Cost of Goods Sold (COGS) incl. D&A 2.45B 2.58B 2.72B 3.21B 3.35B
COGS excluding D&A 1.41B 1.57B 1.66B 2.12B 2.06B
Depreciation & Amortization Expense 1.05B 1.02B 1.06B 1.09B 1.29B
Depreciation 624M 594M 679M 689M 644M
Amortization of Intangibles 425M 423M 381M 399M 642M
Gross Income 12.2B 12.42B 12.97B 13.98B 15.33B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 6.65B 6.88B 7.7B 8.16B 9.26B
Research & Development 2.79B 2.82B 3.17B 3.38B 4.08B
Other SG&A 3.86B 4.05B 4.53B 4.78B 5.18B
Other Operating Expense 0 0 7M 37M 113M
Unusual Expense 377M 352M 1.03B 379M 80M
EBIT after Unusual Expense (377M) (352M) (1.03B) (379M) (80M)
Non Operating Income/Expense 247M 340M 109M 266M 160M
Non-Operating Interest Income 45M 51M 231M 273M 248M
Equity in Affiliates (Pretax) 72M 71M 47M (24M) (6M)
Interest Expense 327M 337M 466M 912M 1.01B
Gross Interest Expense 359M 370M 488M 938M 1.03B
Interest Capitalized 32M 33M 22M 26M 18M
Pretax Income 5.2B 5.32B 4.15B 5.01B 5.27B
Income Tax 599M 690M 467M 664M 184M
Income Tax - Current Domestic 410M 688M 676M 485M 80M
Income Tax - Current Foreign 155M 153M 148M 158M 191M
Income Tax - Deferred Domestic 33M (153M) (356M) 40M (67M)
Income Tax - Deferred Foreign 1M 2M (1M) (19M) (20M)
Income Tax Credits - - - - -
Equity in Affiliates - - - - -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 4.61B 4.63B 3.68B 4.35B 5.08B
Minority Interest Expense 0 0 0 0 0
Net Income 4.61B 4.63B 3.68B 4.35B 5.08B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 4.61B 4.63B 3.68B 4.35B 5.08B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 4.61B 4.63B 3.68B 4.35B 5.08B
EPS (Basic) 4.53 4.82 4.07 5.61 6.75
Basic Shares Outstanding 1.02B 960M 905M 775M 753M
EPS (Diluted) 4.51 4.79 4.04 5.52 6.64
Diluted Shares Outstanding 1.02B 965M 912M 787M 765M
EBITDA 6.59B 6.56B 6.32B 6.87B 7.24B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Amgen Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 14.65B 15.01B 15.69B 17.19B 18.67B
Cost of Goods Sold (COGS) incl. D&A 2.45B 2.58B 2.72B 3.21B 3.35B
COGS excluding D&A 1.41B 1.57B 1.66B 2.12B 2.06B
Depreciation & Amortization Expense 1.05B 1.02B 1.06B 1.09B 1.29B
Depreciation 624M 594M 679M 689M 644M
Amortization of Intangibles 425M 423M 381M 399M 642M
Gross Income 12.2B 12.42B 12.97B 13.98B 15.33B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 6.65B 6.88B 7.7B 8.16B 9.26B
Research & Development 2.79B 2.82B 3.17B 3.38B 4.08B
Other SG&A 3.86B 4.05B 4.53B 4.78B 5.18B
Other Operating Expense 0 0 7M 37M 113M
Unusual Expense 377M 352M 1.03B 379M 80M
EBIT after Unusual Expense (377M) (352M) (1.03B) (379M) (80M)
Non Operating Income/Expense 247M 340M 109M 266M 160M
Non-Operating Interest Income 45M 51M 231M 273M 248M
Equity in Affiliates (Pretax) 72M 71M 47M (24M) (6M)
Interest Expense 327M 337M 466M 912M 1.01B
Gross Interest Expense 359M 370M 488M 938M 1.03B
Interest Capitalized 32M 33M 22M 26M 18M
Pretax Income 5.2B 5.32B 4.15B 5.01B 5.27B
Income Tax 599M 690M 467M 664M 184M
Income Tax - Current Domestic 410M 688M 676M 485M 80M
Income Tax - Current Foreign 155M 153M 148M 158M 191M
Income Tax - Deferred Domestic 33M (153M) (356M) 40M (67M)
Income Tax - Deferred Foreign 1M 2M (1M) (19M) (20M)
Income Tax Credits - - - - -
Equity in Affiliates - - - - -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 4.61B 4.63B 3.68B 4.35B 5.08B
Minority Interest Expense 0 0 0 0 0
Net Income 4.61B 4.63B 3.68B 4.35B 5.08B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 4.61B 4.63B 3.68B 4.35B 5.08B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 4.61B 4.63B 3.68B 4.35B 5.08B
EPS (Basic) 4.53 4.82 4.07 5.61 6.75
Basic Shares Outstanding 1.02B 960M 905M 775M 753M
EPS (Diluted) 4.51 4.79 4.04 5.52 6.64
Diluted Shares Outstanding 1.02B 965M 912M 787M 765M
EBITDA 6.59B 6.56B 6.32B 6.87B 7.24B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)Scroll down for more posts ▼